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PURPOSE. To investigate which cytokines and chemokines are involved in the immunopatho-
genesis of acute retinal necrosis (ARN), and whether cytokine profiles are associated with
clinical manifestations, such as visual outcome.
METHODS. Serum and aqueous humor (AH) samples of 19 patients with ARN were analyzed by
multiplex immunoassay. Infectious controls consisted of 18 patients with rubella virus–
associated Fuchs’ uveitis and 20 patients with ocular toxoplasmosis all confirmed by
intraocular fluid analyses. The control group consisted of seven paired AH and serum samples
from seven noninflammatory control patients with age-related cataract. In each sample, 4 anti-
inflammatory, 12 proinflammatory, 2 vascular, and 4 other immune mediators were measured.
In addition, various clinical characteristics were assessed.
RESULTS. In ARN, 10 of the 22 mediators, including most proinflammatory and vascular
mediators such as IL-6, IL-8, IL-18, MIF, MCP-1, Eotaxin, IP-10, IL-15, sICAM-1, and sVCAM-1,
were significantly elevated when compared to all controls. In addition, one anti-inflammatory
mediator (IL-10) was significantly elevated in ARN as compared to the controls. No association
was found between the time of sampling and the extent and levels of immune mediator
expression.
CONCLUSIONS. The pathogenesis of ARN is characterized by the presence of predominantly
proinflammatory cytokines and chemokines with high expression levels as compared to other
infectious causes of uveitis. There are no indications for an obvious Th-1 or Th-17 pathway.
The combined data suggest that immune mediator expression is related to severity of disease,
which is more fulminant in ARN, rather than to a specific uveitis entity.
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Acute retinal necrosis (ARN) represents an intraocularherpetic infection characterized by severe inflammatory
symptoms, including progressive retinitis and choroiditis with
occlusive vasculitis and papillitis. Acute retinal necrosis has a
poor visual prognosis, due to extensive retinal inflammation
with necrosis, occlusive vasculitis, frequent development of
retinal detachment, and optic disc atrophy.1,2 Varicella zoster
virus (VZV) is the most frequent cause of ARN in adults,3 but it
may also be caused by other members of the herpes virus
family, including herpes simplex virus (HSV) types 1 and 2, and
rarely, cytomegalovirus.4–8 To date, the pathogenesis of
extensive inflammation responsible for visual loss in ARN is
unknown. The necrotic process has been described to be
driven by CD4þT cells, macrophages, polymorphonuclear cells,
B cells, and by the inflammatory cytokines TNF-a and IFN-c.9,10
Which (other) cytokines and chemokines are involved in the
process of ARN has not been fully defined. Only a few
studies11–13 have shown changes in levels of specific cytokines
and chemokines in the aqueous humor (AH) of patients with
ARN. Additionally, most of these studies have investigated a
limited number of patients and/or the quantity of AH available
from each patient has allowed analysis of only a limited number
of mediators. To study the mediators involved in this
devastating inflammatory reaction, a comprehensive spectrum
of immune mediators needs to be measured, in a large cohort of
patients.
The aim of this study was to investigate which cytokines and
chemokines are involved in the immunopathogenesis of ARN,
caused by HSV or VZV, and whether specific cytokine profiles
are associated with clinical manifestations. To this end,
cytokine and chemokine expression patterns in the AH and
serum were determined by multiplex immunoassay (Luminex,
Austin, Texas, USA) technology, highly suited for high-through-
put analysis in microvolumes, including ocular fluids.11,14–16
MATERIALS AND METHODS
Patients
In this study, paired AH and serum samples of 19 patients with
ARN who fulfilled the clinical criteria of the International
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Uveitis Study Group, and confirmed by intraocular fluid
analysis, were included.17 Results were compared to mediator
profiles detected in paired AH and serum samples of 18
patients with rubella virus–associated Fuchs’ uveitis (RV-FU)
and 20 patients with ocular toxoplasmosis (OT). Noninflam-
matory controls consisted of seven paired AH and serum
samples from patients with age-related cataract.
Of the 19 patients with ARN, 4 patients had an HSV
infection, 14 had a VZV infection, and 1 patient had an HSV/
VZV double infection, all confirmed by PCR and by establishing
specific intraocular antibody production with the Goldmann-
Witmer coefficient (GWC). The infectious cause of OT and RV-
FU uveitis was also determined by PCR and GWC, as described
previously.18–21 All samples were collected for diagnostic
purposes and their remainders were used for the current
examinations. This study was conducted according to the
tenets of the Declaration of Helsinki. None of the patients
objected to the use of the remnants of their samples for further
research and this study was approved by the institutional
review board of the University Medical Center Utrecht.
The following clinical data were assessed for each patient:
sex, age at the time of sampling, time interval between onset of
uveitis and sample collection, and (systemic) treatment at the
time of sampling. All ARN patients were treated with
intravenous acyclovir and none of the patients used steroids
at the time of sampling. One OT patient was on antimicrobial
medication for 4 days at time of sampling.
Aqueous humor and serum samples were collected as
described previously, stored at808C in sterile screw-cap tubes
within 5 hours of collection, and thawed directly before
analysis to preserve the sample.22
Multiplex Immunoassay
Twenty-five microliters of AH and 50 lL serum sample were
analyzed by multiplex immunoassay essentially as described
previously.14 In each sample, 22 immune mediators were
analyzed: 4 anti-inflammatory cytokines (interleukin [IL]-4, IL-
5, human-specific IL-10, and IL-13); 12 proinflammatory
mediators (cytokines IL-1b, IL-2, IL-6, IL-12p70, IL-17, IL-18,
interferon-c [IFN-c], tumor necrosis factor-a [TNF-a], and
chemokines IL-8 [CXCL8], interferon-inducible 10-kDa protein
[IP-10; CXCL10], monocyte chemotactic protein-1 [MCP-1;
CCL2], macrophage inflammatory protein-1-a [MIP1a; CCL3]);
2 vascular mediators (soluble vascular cell adhesion molecule
[sVCAM-1] and soluble intracellular adhesion molecule [sICAM-
1]); and 4 additional mediators (cytokines IL-15 and macro-
phage migration inhibitory factor [MIF], and chemokines
RANTES [regulated on activation, normal T-cell expressed
and secreted; [CCL5] and Eotaxin [CCL11]). Concentrations
above or below the detection limit were assigned as the
highest or the lowest value from the respective standard curve.
For statistical analysis, concentrations below the detection
limit were converted to a value of 0.53, the lowest value of the
standard curve.14 The assay sensitivities for each mediator are
listed in the footnotes of Tables 1 and 2.
Statistical Analysis
Principal component analysis (PCA) was performed on log-
transformed mediator concentrations. Cluster analysis was
performed by using 1-Pearson’s correlation as a distance
measure and Ward’s method for hierarchical clustering as
before.23 The PCA and the cluster analysis were performed and
visualized in R, a language for statistical computing (http://
www.r-project.org; in the public domain).
Additional statistical analyses of the data were performed by
using SPSS version 21 (SPSS, Inc., Chicago, Illinois, USA).
Kruskal-Wallis and Mann-Whitney U test were used for
nonparametric comparison of the different groups. An
overview of the data and initial Kruskal-Wallis test for AH and
serum are shown in Tables 1 and 2, respectively. In Mann-
Whitney U tests, Bonferroni correction was used to compen-
sate for multiple comparisons. Correlations were determined
by the Spearman’s q test. Visual acuity was converted into the
logMAR (logarithm of the minimum angle of resolution) visual
acuity. P values of less than 0.05 were considered to be
statistically significant.
RESULTS
Cluster Analysis Identifies a Distinct Group of
Highly Expressed Cytokines That Associates With
ARN
As a first step in the analysis, we applied cluster analysis to
obtain a global overview of cytokine expression in the AH.
Contrary to conventional analysis, this analysis method does
not divide the samples into a priori groups but aggregates them
on the basis of similarity to each other (i.e., nonsupervised
analysis; Fig. 1A). Application of this method to our data shows
that the samples can be divided into three principal groups:
one consisting primarily of ARN (Fig. 1A, cluster A) and two
mixed groups (Fig. 1A, clusters B and C). The noninflammatory
controls fall primarily in a subgroup of the bottom compart-
ment in cluster C, while OT and RV-FU samples do not separate
clearly from each other or from the controls. This analysis was
confirmed by using PCA (Fig. 1B), a technique that uses all AH
measurements to evaluate the extent to which samples are
alike and projects this into a 2D plot. Principal component
analysis data showed that ARN samples appear to contain
different cytokines when compared to the other disease
categories, as these segregated from the other samples on
the first principal component that accounts for two-thirds of all
variability in the data (66%) (Fig. 1B).
Cluster analysis further showed that the three clusters
segregate primarily by the expression of a subset of cytokines,
including IP-10, sVCAM-1, sICAM-1, MCP-1, Eotaxin, MIF, IL-8,
IL-6, RANTES, IL-10, and IL-18, ranging from high, intermediate,
and low levels in clusters A, B, and C, respectively. The control
subgroup in cluster C segregated primarily on cytokines IL-
12p70, MIP1a, TNF-a, and IL-13; a similar subgroup based on
these cytokines was observed in the ARN-dominated cluster A.
Statistical Analysis of Differences in Cytokine
Expression Between ARN and Controls
Further statistical analysis by Mann-Whitney U testing con-
firmed the cluster analysis observations described above.
Similarly, in the ocular fluids of the ARN patients, IP-10,
sVCAM-1, sICAM-1, MCP-1, Eotaxin, MIF, IL-8, IL-6, IL-10, and IL-
18 were significantly elevated as compared to the noninflam-
matory controls (Fig. 2; Table 3). Proinflammatory mediators
IL-6, IL-8, IL-18, IP-10, and MCP-1, as well as Eotaxin and
vascular chemokines, were significantly elevated as compared
to all controls (Table 1). Only one anti-inflammatory mediator,
IL-10, was significantly elevated.
Acute retinal necrosis samples contained significantly
higher levels of IFN-c than RV-FU samples (P ¼ 0.039; Mann-
Whitney U test with Bonferroni correction), but not compared
to OT (P¼ 0.114) (Fig. 2). Proinflammatory mediator IL-12 was
not detected in ARN patients but was significantly elevated in
OT (P ¼ 0.003; Mann-Whitney U test with Bonferroni
correction) and RV-FU (P ¼ 0.039; Mann-Whitney U test with
Bonferroni correction).
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TABLE 1. Immune Mediator Expression in Aqueous Humor Samples
Mediator ARN (n ¼ 19) RV-FU (n ¼ 18) OT (n ¼ 20) NIC (n ¼ 7) P Value*
IL-1b
Mean, pg/mL† 1 n.a. <1 n.a. 0.068
Range or values, pg/mL‡ <1.5 to 17 n.a. 6.2 n.a.
No. detected (%)§ 4 (21) 0 1 (5) 0
IL-2
Mean, pg/mL† n.a. 3 n.a. n.a. 0.158
Range or values, pg/mL‡ n.a. 35.3; 70.5 n.a. n.a.
No. detected (%)§ 0 2 (11) 0 0
IL-4
Mean, pg/mL† 2 n.a. <1 n.a. 0.017
Range or values, pg/mL‡ <1.2 to 35.4 n.a. 2.8; 12.8 n.a.
No. detected (%)§ 6 (32) 0 2 (10) 0
IL-5
Mean, pg/mL† 4 2 2 n.a. 0.072
Range or values, pg/mL‡ <1.2 to 74.7 36.4 49.6 n.a.
No. detected (%)§ 5 (26) 1 (6) 1 (5) 0
IL-6
Mean, pg/mL† 3246 27 32 458 0
Range or values, pg/mL‡ 169 to >10,016 <2.4 to 9299 <2.4 to >10,016 <2.4 to 3191
No. detected (%)§ 19 (100) 11 (61) 14 (70) 1 (14)
IL-10
Mean, pg/mL† 51 <1 1 n.a. 0
Range or values, pg/mL‡ <2.3 to 559 3.7 <2.3 to 20.7 n.a.
No. detected (%)§ 18 (95) 1 (6) 5 (25) 0
IL-12p70
Mean, pg/mL† 2 7 6 n.a. 0
Range or values, pg/mL‡ 11.1 <4.3 to 68.4 <4.3 to 81.1 n.a.
No. detected (%)§ 1 (5) 9 (50) 13 (65) 0
IL-13
Mean, pg/mL† 1 1 1 n.a. 0.321
Range or values, pg/mL‡ <1 to 50.0 <1 to 21.9 <1 to 28.3 n.a.
No. detected (%)§ 6 (32) 7 (39) 6 (30) 0
IL-15
Mean, pg/mL† 26 25 45 16 0.038
Range or values, pg/mL‡ <1.4 to 93.8 <1.4 to 171 12.3 to 112 <1.4 to 50.3
No. detected (%)§ 16 (84) 16 (89) 20 (100) 4 (57)
IL-17
Mean, pg/mL† 2 n.a. 2 n.a. 0.727
Range or values, pg/mL‡ 20 n.a. 8.7 n.a.
No. detected (%)§ 1 (5) 0 1 (5) 0
IL-18
Mean, pg/mL† 28 n.a. 2 2 0
Range or values, pg/mL‡ <1.2 to 155 n.a. <1.2 to 110 9.2
No. detected (%)§ 17 (89) 0 4 (20) 1 (14)
IFN-c
Mean, pg/mL† 15 n.a. 3 n.a. 0.001
Range or values, pg/mL‡ <9.1 to 1246 n.a. <9.1 to 294 n.a.
No. detected (%)§ 9 (47) 0 4 (20) 0
TNF-a
Mean, pg/mL† 2 2 2 n.a. 0.338
Range or values, pg/mL‡ <1.2 to 60.7 <1.2 to 30.0 <1.2 to 21.9 n.a.
No. detected (%)§ 6 (32) 6 (33) 8 (40) 0
sICAM-1
Mean, pg/mL† 34,668 1458 2038 9644 0
Range or values, pg/mL‡ 4750 to >81,387 161 to 23,999 254 to >81,387 <26.4 to 51,603
No. detected (%)§ 19 (100) 18 (100) 20 (100) 6 (86)
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Further correlation analyses of mediators in the AH of ARN
patients showed that IFN-c expression correlated with that of
TNF-a (r¼ 0.71, P¼ 0.001) and IL-18 (r¼ 0.46, P¼ 0.050), but
not with that of IL-12 (Table 4). Expression of IL-8 correlated
with that of MCP-1 (r¼0.59, P¼0.008), but not with that of IP-
10. Soluble ICAM-1 and sVCAM-1 expression correlated with
that of IP-10 (r¼ 0.51, P¼ 0.026 for both), as well as with that
of IL-8 (r ¼ 0.74, P ¼ 0.000 and r ¼ 0.79, P ¼ 0.000,
respectively), but not with that of MCP-1 (Table 4). Interleukin
10, the only significantly elevated anti-inflammatory cytokine,
correlated with IL-6 (r ¼ 0.60, P ¼ 0.007), IL-8 (r ¼ 0.46, P ¼
0.049), IP-10 (r¼ 0.53, P¼ 0.019), IFN-c (r¼ 0.82, P¼ 0.000),
MCP-1 (r¼ 0.71, P¼ 0.001), and Eotaxin (r¼ 0.70, P¼ 0.001),
but not with IL-12, IL-18, sICAM-1, sVCAM-1, and RANTES.
Analysis of the interval between the onset of symptoms and
time of sampling did not reveal an association with the level
and extend of cytokine and chemokine production.
Analysis of the serum levels demonstrated that all cytokine
and chemokine levels, except for RANTES, were lower than
those found in the ocular fluids (Tables 1, 2). In contrast, the
levels of the vascular mediators sVCAM-1 and sICAM-1 were in
almost all cases higher in the serum than in the ocular fluid
samples.
DISCUSSION
In this study, analysis of AH samples of ARN patients revealed
an increased production of mainly proinflammatory cytokines
and chemokines as compared to AH samples of the infectious
and noninflammatory controls. Also, vascular mediators, such
as sICAM-1 and sVCAM-1, appeared to be more prevalent in
ARN than in the other uveitis entities. Acute retinal necrosis
AH samples contained a wider spectrum of mediators and
these were produced in higher quantities. Most notably, the
levels of proinflammatory mediators IL-6, IL-8, IP-10, and MCP-
1, attracting neutrophils, T lymphocytes, and monocytes, are
significantly higher in ARN than in the other uveitis
TABLE 1. Continued
Mediator ARN (n ¼ 19) RV-FU (n ¼ 18) OT (n ¼ 20) NIC (n ¼ 7) P Value*
sVCAM-1
Mean, pg/mL† 36,846 3041 2579 13,800 0
Range or values, pg/mL‡ 6169 to >95,705 248 to 28,986 <25.0 to >95,705 <25.0 to 47,451
No. detected (%)§ 19 (100) 18 (100) 19 (95) 5 (71)
RANTES
Mean, pg/mL† 47 6 9 24 0.001
Range or values, pg/mL‡ <4.6 to 634 433 <4.6 to 262 138
No. detected (%)§ 12 (63) 1 (6) 4 (20) 1 (14)
Eotaxin
Mean, pg/mL† 332 4 5 2 0
Range or values, pg/mL‡ 9 to 3975 <1.3 to 328.9 <1.3 to 1218.5 8.7
No. detected (%)§ 19 (100) 8 (44) 10 (50) 1 (14)
IL-8
Mean, pg/mL† 784 10 9 11 0
Range or values, pg/mL‡ 24 to >2483 <1.3 to 63.9 <1.3 to 878.9 17.4; 51.0
No. detected (%)§ 19 (100) 12 (67) 12 (60) 2 (29)
IP-10
Mean, pg/mL† 2102 103 169 338 0
Range or values, pg/mL‡ 228 to >2468 <1.0 to >2468 <1.0 to >2468 32.7; 731; 1598
No. detected (%)§ 19 (100) 13 (72) 17 (85) 3 (43)
MIP1a
Mean, pg/mL† 46 15 14 n.a. 0.022
Range or values, pg/mL‡ <9.3 to 805 180; 241; 288 72.9; 249; 414 n.a.
No. detected (%)§ 9 (47) 3 (17) 3 (15) 0
MCP-1
Mean, pg/mL† 2738 625 420 181 0
Range or values, pg/mL‡ 759 to >4513 26.6 to 3919 72.0 to 3120 22.3 to 412
No. detected (%)§ 19 (100) 18 (100) 20 (100) 7 (100)
MIF
Mean, pg/mL† 1967 90 80 138 0
Range or values, pg/mL‡ 240 to >10,000 <18.0 to 1962 <18.0 to 1089 175; 268; 451
No. detected (%)§ 19 (100) 10 (56) 11 (55) 3 (43)
Assay sensitivities in pg/mL are 1.5 for IL-1b, 1.8 for IL-2, 1.2 for IL-4, 1.2 for IL-5, 2.4 for IL-6, 2.3 for IL-10, 4.3 for IL-12p70, 1.0 for IL-13, 1.4 for
IL-15, 1.1 for IL-17, 1.2 for IL-18, 9.1 for IFN-c, 1.2 for RANTES (CCL5), 1.3 for Eotaxin (CCL11), 5.3 for IL-8 (CXCL8), 1.0 for IP-10 (CXCL10), 1.2 for
TNF-a, 4.7 for MIF, 1.2 for MCP-1 (CCL2), 9.3 for MIP1a (CCL3), 25.0 for sVCAM-1 (CD106), and 26.4 for sICAM-1 (CD54) (de Jager et al.,14 2005). IP,
interferon-inducible protein; n.a., not applicable; NIC, noninflammatory controls.
* P value calculated by using the Kruskal-Wallis test.
† Geometric mean concentration (pg/mL).
‡ Range of measured concentrations (pg/mL). For fewer than four detectable samples, the values are given.
§ Number of samples above the lower limit of detection.
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TABLE 2. Immune Mediator Expression in Serum Samples
Mediator ARN (n ¼ 19) RV-FU (n ¼ 18) OT (n ¼ 20) NIC (n ¼ 7) P Value*
IL-1b
Mean, pg/mL† <1 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 13.5 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
IL-2
Mean, pg/mL† 3 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 118 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
IL-4
Mean, pg/mL† <1 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 37.5 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
IL-5
Mean, pg/mL† 2 n.a. 2 n.a. 0.44
Range or values, pg/mL‡ 58.9; 902 n.a. 15.4; 135 n.a.
No. detected (%)§ 2 (11) 0 2 (10) 0
IL-6
Mean, pg/mL† 5 3 3 n.a. 0.336
Range or values, pg/mL‡ 2.4 to 3737 41.3 13.6; 23.4 n.a.
No. detected (%)§ 4 (21) 1 (6) 2 (10) 0
IL-10
Mean, pg/mL† <1 n.a. n.a. n.a. 0.003
Range or values, pg/mL‡ 79.4 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
IL-12p70
Mean, pg/mL† 1 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 79.2 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
IL-13
Mean, pg/mL† 1 n.a. 1 n.a. 0.727
Range or values, pg/mL‡ 134 n.a. 28.2 n.a.
No. detected (%)§ 1 (5) 0 1 (5) 0
IL-15
Mean, pg/mL† 1 n.a. 2 7 0.203
Range or values, pg/mL‡ 4.5; 92.5 n.a. 15.2; 30.4; 39.2 18.1; 23.6
No. detected (%)§ 2 (11) 0 3 (15) 2 (29)
IL-17
Mean, pg/mL† 2 1 2 2 0.817
Range or values, pg/mL‡ <1.1 to 71.0 <1.1 to 14.3 <1.1 to 57.0 11.1
No. detected (%)§ 5 (26) 4 (22) 6 (30) 1 (14)
IL-18
Mean, pg/mL† 26 24 27 31 0.361
Range or values, pg/mL‡ 8.0 to 316 13.4 to 63.9 8.4 to 68.8 3.1 to 121
No. detected (%)§ 19 (100) 18 (100) 20 (100) 7 (100)
IFN-c
Mean, pg/mL† <1 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 180 n.a. n.a. n.a.
No. detected (%)§ 1 (5) 0 0 0
TNF-a
Mean, pg/mL† 1 n.a. n.a. n.a. 0.5
Range or values, pg/mL‡ 30.7 n.a. n.a. n.a.
No detected (%)§ 1 (5) 0 0 0
sICAM-1
Mean, pg/mL† 86,360 53,183 82,689 80,718 0.321
Range or values, pg/mL‡ 75,860 to >86,985 28.7 to >86,985 31,590 to >86,985 48,848 to >86,985
No. detected (%)§ 19 (100) 17 (94) 20 (100) 7 (100)
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entities.24–27 Interestingly, the typical proinflammatory medi-
ators IL1-b, IL-12, IFN-c, TNF-a, and IL-17 were detected in a
minority of patients. Apparently, the pathogenesis of ARN is
not generally characterized by a typical Th-1 or Th-17 pathway.
High level expression of IL-6, IL-8, IP-10, and MCP-1 has
been previously reported for herpetic and noninfectious
uveitis entities.11,12,28–31 Low expression levels of IL1-b, IL-2,
IL-12, TNF-a, and IL-17 are reported for other infectious and
noninfectious uveitis entities.11–13,28–33 Contrary to our study,
others have reported high IFN-c expression in both infectious
and noninfectious uveitis, although Ongkosuwito et al.12 and
Lahmar et al.31 also have found IFN-c in only about half of their
viral uveitis cases.11–13,28–31,33 Low level expression for the Th-
2–type cytokines IL-4, IL-5, and IL-13 has also been reported for
infectious and noninfectious uveitis.11–13,31,33 Moreover, high
IL-10 expression has been previously reported for herpetic
uveitis and is mostly low in noninfectious uveitis enti-
ties.11,28,29,31,34 The expression of IL-15, RANTES, and Eotaxin
is consistent with other reports for both infectious and
noninfectious uveitis.11,28,32,34
Interferon-c was detected in 47% of ARN patients. It serves
as an antiviral cytokine by inhibiting viral replication or
eliminating viruses from infected cells35 and has been
described to be one of the factors that plays an important
role in the clinical course of ARN.36 Also, the level of IFN-c has
been shown to affect the severity of clinical signs of some viral
infectious diseases.37,38 The IFN-c response is enhanced by
TNF-a, which is a proinflammatory cytokine involved in
systemic inflammation.39 In this study, TNF-a was detected in
approximately 30% of the aqueous of the ARN patients and it
correlated with IFN-c. Similar to our findings, Ongkosuwito et
al.12 and Lahmar et al.31 have found significantly increased IFN-
c levels in AH samples of 41% and 57% of ARN patients,
respectively. The differences in IFN-c detection between ARN
patients may be attributed to the timing of sampling, which
varies in our study from 1 day up to 4 weeks after initiation of
complaints. Levels may have dropped to undetectable levels
TABLE 2. Continued
Mediator ARN (n ¼ 19) RV-FU (n ¼ 18) OT (n ¼ 20) NIC (n ¼ 7) P Value*
sVCAM-1
Mean, pg/mL† 110,562 62,549 100,216 112,484 0.214
Range or values, pg/mL‡ 78,474 to >112,820 41.0 to >112,820 10,555 to >112,820 110,472 to >112,820
No. detected (%)§ 19 (100) 17 (94) 20 (100) 7 (100)
RANTES
Mean, pg/mL† 4737 1704 5541 5091 0.017
Range or values, pg/mL‡ 1486 to >5541 <4.6 to >5541 >5541 3805 to >5541
No. detected (%)§ 19 (100) 16 (89) 20 (100) 7 (100)
Eotaxin
Mean, pg/mL† 33 6 43 23 0.073
Range or values, pg/mL‡ <1.3 to 367 <1.3 to 115 3.0 to 217 7.8 to 45.1
No. detected (%)§ 18 (95) 10 (56) 20 (100) 7 (100)
IL-8
Mean, pg/mL† 58 12 5 5 0.003
Range or values, pg/mL‡ <1.3 to 2806 2.6 to 102 <1.3 to 827 1.8 to 14.4
No. detected (%)§ 17 (89) 18 (100) 12 (60) 7 (100)
IP-10
Mean, pg/mL† 20 6 18 21 0.026
Range or values, pg/mL‡ <1.0 to 222 <1.0 to 186 <1.0 to 72.7 2.7 to 84.6
No. detected (%)§ 18 (95) 8 (44) 19 (95) 7 (100)
MIP1a
Mean, pg/mL† 33 15 14 47 0.116
Range or values, pg/mL‡ <9.3 to 4682 70.6; 92.9; 180 54.9; 79.6; 149 73.2; 208
No. detected (%)§ 9 (47) 3 (17) 3 (15) 2 (29)
MCP-1
Mean, pg/mL† 97 72 76 55 0.145
Range or values, pg/mL‡ 36.5 to 312 19.8 to 212 21.0 to 215 10.8 to 131
No. detected (%)§ 19 (100) 18 (100) 20 (100) 7 (100)
MIF
Mean, pg/mL† 178 136 62 147 0.141
Range or values, pg/mL‡ <13.8 to 5733 <13.6 to 2243 <13.6 to 1814 <13.8 to 505
No. detected (%)§ 18 (95) 13 (72) 10 (50) 4 (57)
Assay sensitivities in pg/ml are 1.5 for IL-1b, 1.8 for IL-2, 1.2 for IL-4, 1.2 for IL-5, 2.4 for IL-6, 2.3 for IL-10, 4.3 for IL-12p70, 1.0 for IL-13, 1.4 for IL-
15, 1.1 for IL-17, 1.2 for IL-18, 9.1 for IFN-c, 1.2 for RANTES (CCL5), 1.3 for Eotaxin (CCL11), 5.3 for IL-8 (CXCL8), 1.0 for IP-10 (CXCL10), 1.2 for
TNF-a, 4.7 for MIF, 1.2 for MCP-1 (CCL2), 9.3 for MIP1a (CCL3), 25.0 for sVCAM-1 (CD106), and 26.4 for sICAM-1 (CD54) (de Jager et al.,14 2005).
* P value calculated by using the Kruskal-Wallis test.
† Geometric mean concentration (pg/mL).
‡ Range of measured concentrations (pg/ml). For fewer than four detectable samples, the values are given.
§ Number of samples above the lower limit of detection.
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FIGURE 1. (A) Heat map of aqueous humor cytokine concentrations. Cytokine concentrations are depicted as colors ranging from cyan to black to
red, indicating low, intermediate, and high concentration, respectively, relative to the mean of that cytokine. The phenotype of the samples is
indicated by the label on the right as well as by the colored bar on the left. Samples are separated in one of three clusters (A, B, and C) indicated in
gray. (B) Principal component analysis of aqueous humor samples, with the x- and y-axes representing the first and second principal components.
The fraction of variation that is explained by each axis is noted in its label. The ARN samples are segregated from the other samples on the first
principal component (PC1) that accounts for two-thirds of all variability in the data (66%). The phenotype of the individual samples is color
indicated. Control, noninflammatory control.
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within the clinical course of the disease as described by Abe et
al.36
The ARN samples contained high levels of IL-18, whereas
this cytokine was undetectable in RV-FU and only detectable in
four OT samples. In mice, high levels of IL-18 have been
associated with damage to the retinal pigment epithelium by
inducing apoptosis.40,41 Possibly, IL-18 contributes to the
extent of retinitis in ARN patients, although no correlation
FIGURE 2. Dot plots of immune mediators significantly elevated in the ocular fluids of patients with ARN as compared to immune mediators in the
ocular fluids of patients with RV-FU, OT, and noninflammatory controls (Controls). Significant P values are noted in the upper part of each graph.
Statistical analysis was done with Mann-Whitney U tests followed by Bonferroni correction to compensate for multiple comparisons. A P value <
0.05 was considered significant.
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was found between IL-18 expression and the presence of
ablatio retinae.
Proinflammatory cytokine IL-12, while virtually absent in
ARN, was elevated in RV-FU and OT, which is in concordance
with other publications.11,27,31,42 The lack of IL-12 in ARN
samples may reflect negative feedback on IL-12 expression by
IL-10, which was significantly increased.43 Moreover, as IL-12 is
a potent inducer of IFN-c, the lack of IL-12 may explain why
INF-c was not significantly increased in our ARN cohort
compared to the controls, contrary to other reports.11,27,42 The
FIGURE 2. Continued.
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observed correlation between IFN-c and IL-18 in ARN and OT
and the lack of correlation between IFN-c and IL-12 in all three
entities may indicate that in AH, IFN-c is predominantly under
regulatory control of IL-18 rather than of IL-12.
IP-10, which is under the control of IFN-c, was expressed to
high levels in all ARN patients, despite the presence of IFN-c in
only 47% of ARN patients. Maybe, IP-10 can be induced by
another yet to be identified cytokine, for example, IL-18, which
was expressed in 89% of ARN cases.
In our study, the cell adhesion molecules sICAM-1 and
sVCAM-1 were elevated in the AH of all uveitis entities;
however, they were more elevated in ARN than in the controls
and both molecules correlated with IL-8. Soluble ICAM-1
mediates tight adhesion between all leukocytes and vascular
endothelium, whereas sVCAM-1 mediates tight adhesion
between lymphocytes, monocytes, and vascular endothelium
before migration into the tissues.39,44 Possibly, in case of viral
infection of the retina, proinflammatory cytokines and chemo-
attractants, such as IL-8, are upregulated at the site of
inflammation.39 Concomitantly, infiltration of inflammatory
cells occurs by adhesion of leukocytes to the vascular
endothelium, mediated by VCAM-1– and ICAM-1–mediated
receptor–ligand interactions, causing occlusive vasculitis.39
During inflammation, adhesion molecules on endothelial cells
are induced by vascular endothelial growth factor (VEGF).
VEGF plays a major role in the development of intraocular
neovascularizations, induces blood–retina barrier breakdown,
and consequently increases vascular permeability. It is de-
scribed as being highly elevated in the ocular fluids of patients
with ARN, especially in patients with extensive retinitis.2 This
proinflammatory process, reminiscent of the so-called cytokine
storm described for many inflammatory diseases including
those of viral origin, will lead to extensive inflammation
resulting in severe tissue damage.45
Our results showed that ARN is characterized by mainly a
proinflammatory response. However, all but one ARN patient
intraocularly expressed high levels of anti-inflammatory IL-10,
which was significantly elevated as compared to the controls.
Increased IL-10 production in herpes uveitis has been reported
previously. Interleukin 10 is an immunosuppressive regulatory
cytokine that enhances B-lymphocyte survival and antibody
production.39 Interleukin 10 can be produced by T lympho-
cytes, and it has been proposed that IL-10 downregulates the
immune responses in order to dampen T-cell–mediated immune
reactions and thereby control the extent of tissue damage.46–50
The high IL-10 levels observed in the ocular fluids of the ARN
patients seem paradoxal regarding the severe course of the
disease. Possibly, the levels of IL-10 are not sufficient to dampen
the harmful immune responses. Alternatively, immune respons-
es other than those downregulated by IL-10 or other
mechanisms all together may contribute to the damage, such
as oxidative stress. Both infiltrating leukocytes and ocular
resident cells, such as retinal pigmented epithelium and glial
cells, can produce cytokines.10,51 Therefore, the results
presented here most likely represent the combined mediator
expression from lymphocytes and ocular resident cells, possibly
in response to each other. Limitations of our study included the
differences in sampling timing within the cohort, which may be
overcome by performing longitudinal follow-up studies in
individual ARN patients. This may provide valuable insight into
the course of the inflammatory process in ARN.
The question arises whether cytokine profiles might be
discriminative for the diagnosis of various infectious uveitis
entities. Our hierarchical cluster analysis and PCA might
suggest that ARN is characterized by the intraocular expression
of a specific set of immune mediators. Lahmar et al.31 have
suggested that cytokines may be used as diagnostic markers, as
they have found IL-5 and IL-12 to be specific for OT, and IL-1b
for viral uveitis. In our study, we also found IL-12 expression in
OT and not in ARN; however, the reported association with IL-
5 expression was not observed, and IL-1b was detected in only
4 of 19 ARN patients. In addition, the expression of other
markers also differed between the study of Lahmar et al.31 and
ours. Moreover, the hierarchical cluster analysis and PCA (Fig.
1) showed that among ARN patients, clear differences in
mediator expression levels may exist, as observed in the data
by Lahmar et al.31 In addition, in both studies, OT patients
were observed who had a mediator profile similar to that of
some ARN/viral uveitis patients. These inconsistencies might
be explained by the fact that cytokine and chemokine
expression patterns are part of an intricate regulatory network,
which depends on many environmental stimuli, and may
therefore vary considerably during the course of disease,
which limits their use for diagnostic purposes. This is also
reflected by the similarities in cytokine profiles between RV-FU
and OT, while the causative agent of these ocular diseases is
notably different: virus versus parasite, respectively. Possibly, in
these patients inflammation has reached the chronic state such
that the cytokine/chemokine profile has become similar in
both ocular diseases. Therefore, immune mediator profiles in
AH seem to provide more insight in severity and stage of the
inflammatory process than etiologic clues.
In conclusion, we found an increased production of
predominantly proinflammatory cytokines and chemokines in
the ocular fluids of patients with ARN. The higher levels of
mainly proinflammatory cytokines and chemokines in ARN
might be a reflection of the more severe inflammation in ARN
rather than a disease-specific cytokine pattern, although IL-10
and IL-18, and to a lesser extent IFN-c, appear to play a more
important role in ARN than in other infectious uveitis entities.
TABLE 3. Statistical Data of Immune Mediator Expression in Ocular
Fluids of Patients With Acute Retinal Necrosis, Other Infectious Uveitis
Entities, and Noninfectious Controls
Classification Name
ARN vs.
RV-FU
ARN vs.
OT
ARN vs.
NIC
Anti-inflammatory IL-4 0.315 0.672 0.693
IL-5 0.651 0.741 0.334
IL-10 0.000  0.000  0.000 
IL-13 1.000 1.000 0.693
Proinflammatory IL-1b 0.852 1.000 1.000
IL-2 1.000 1.000 1.000
IL-6 0.000  0.000  0.000 
IL-8 0.000  0.000  0.000 
IL-12p70 0.039  0.003  1.000
IL-17 1.000 1.000 1.000
IL-18 0.000  0.000  0.000 
IP-10 0.000  0.000  0.000 
IFN-c 0.039  0.252 0.219
TNF-a 1.000 1.000 0.693
MCP-1 0.000  0.000  0.000 
MIP1a 0.315 1.000 0.219
Vascular sVCAM-1 0.000  0.000  0.021 
sICAM-1 0.000  0.000  0.003 
Other IL-15 1.000 1.000 0.105
Eotaxin 0.000  0.000  0.000 
RANTES 0.012  0.027  0.189
MIF 0.000  0.000  0.000 
Represented are P values from pairwise comparison between ARN
and the other three groups, using the Mann-Whitney U test followed by
Bonferroni correction for multiple testing. Significant differences (P <
0.05) are in bold. , significant increase compared to controls, ,
significant decrease compared to controls.
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Future studies of intraocular immune mediators will help to
further understand the immunopathogenesis of ARN.
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